Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (SHA:600866)
China · Delayed Price · Currency is CNY 7.12
-0.12 (-1.66%)
At close: Feb 13, 2026
SHA:600866 Revenue
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong had revenue of 3.92B CNY in the quarter ending September 30, 2025, a decrease of -8.96%. This brings the company's revenue in the last twelve months to 16.62B, down -4.66% year-over-year. In the year 2024, Star Lake Bioscience Co., Inc.Zhaoqing Guangdong had annual revenue of 17.33B, down -0.23%.
Revenue (ttm)
16.62B
Revenue Growth
-4.66%
P/S Ratio
0.71
Revenue / Employee
1.79M
Employees
9,293
Market Cap
11.83B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 17.33B | -39.32M | -0.23% |
| Dec 31, 2023 | 17.37B | -112.59M | -0.64% |
| Dec 31, 2022 | 17.49B | 13.42B | 329.51% |
| Dec 31, 2021 | 4.07B | 2.95B | 264.72% |
| Dec 31, 2020 | 1.12B | 66.67M | 6.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pacific Shuanglin Bio-pharmacy | 2.38B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 1.96B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 1.90B |
| Aurisco Pharmaceutical | 1.62B |
| Vcanbio Cell & Gene Engineering Corp., | 1.47B |
| Chengdu Easton Biopharmaceuticals | 1.33B |
| Hualan Biological Vaccine | 976.44M |
| HitGen | 498.51M |